Availability and costs of medicines for the treatment of tuberculosis in Europe.
- DOI
- 10.1016/j.cmi.2022.07.026
- Published
- 2023 Jan
- Container
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cmi.2022.07.026,
title = {Availability and costs of medicines for the treatment of tuberculosis in Europe.},
author = {Günther G and Guglielmetti L and Leu C and Lange C and van Leth F and Tuberculosis Network European Trials group},
year = {2023},
journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
doi = {10.1016/j.cmi.2022.07.026},
url = {https://doi.org/10.1016/j.cmi.2022.07.026}
}RIS
TY - JOUR TI - Availability and costs of medicines for the treatment of tuberculosis in Europe. AU - Günther G AU - Guglielmetti L AU - Leu C AU - Lange C AU - van Leth F AU - Tuberculosis Network European Trials group PY - 2023 JO - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases DO - 10.1016/j.cmi.2022.07.026 UR - https://doi.org/10.1016/j.cmi.2022.07.026 ER -
APA
G, G., L, G., C, L., C, L., F, V. L., & group, T. N. E. T. (2023). Availability and costs of medicines for the treatment of tuberculosis in Europe.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2022.07.026
Source records
- pubmed · retrieved 2026-09-25T19:13:15.228Z
- europe-pmc · retrieved 2026-09-25T19:13:15.228Z
- hal · retrieved 2026-09-25T19:13:15.268Z